| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Usage # |
|---|
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ExplanationOfBenefit.use.json | R5: claim | preauthorization | predetermination (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Expression.description.json | R5: Natural language description of the condition (new) | trial-use | 0 | fhir | 2026-03 | uv | |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Expression.expression.json | R5: Expression in specified language (new) | trial-use | 0 | fhir | 2026-03 | uv | |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Expression.reference.json | R5: Where the expression is found (new) | trial-use | 0 | fhir | 2026-03 | uv | |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ExtendedContactDetail.address.json | R5: Address for the contact (new) | trial-use | 0 | fhir | 2026-03 | uv | |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ExtendedContactDetail.name.json | R5: Name of an individual to contact (new) | trial-use | 0 | fhir | 2026-03 | uv | |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ExtendedContactDetail.organization.json | R5: This contact detail is handled/monitored by a specific organization (new) | trial-use | 0 | fhir | 2026-03 | uv | |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ExtendedContactDetail.period.json | R5: Period that this contact was valid for usage (new) | trial-use | 0 | fhir | 2026-03 | uv | |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ExtendedContactDetail.purpose.json | R5: The type of contact (new) | trial-use | 0 | fhir | 2026-03 | uv | |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ExtendedContactDetail.telecom.json | R5: Contact details (e.g.phone/fax/url) (new) | trial-use | 0 | fhir | 2026-03 | uv | |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-FamilyMemberHistory.con.contributedToDeath.json | R5: Whether the condition contributed to the cause of death (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-FamilyMemberHistory.instantiatesCanonical.json | R5: Instantiates FHIR protocol or definition additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-FamilyMemberHistory.instantiatesUri.json | R5: Instantiates external protocol or definition (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-FamilyMemberHistory.sex.json | R5: sex additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-FormularyItem.code.json | R5: Codes that identify this formulary item (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-FormularyItem.status.json | R5: active | entered-in-error | inactive (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-GenomicStudy.analysis.json | R5: Genomic Analysis Event (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-GenomicStudy.basedOn.json | R5: Event resources that the genomic study is based on (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-GenomicStudy.description.json | R5: Description of the genomic study (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-GenomicStudy.encounter.json | R5: The healthcare event with which this genomics study is associated (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-GenomicStudy.instantiatesCanonical.json | R5: The defined protocol that describes the study (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-GenomicStudy.instantiatesUri.json | R5: The URL pointing to an externally maintained protocol that describes the study (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-GenomicStudy.interpreter.json | R5: Healthcare professionals who interpreted the genomic study (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-GenomicStudy.note.json | R5: Comments related to the genomic study (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-GenomicStudy.reason.json | R5: Why the genomic study was performed (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-GenomicStudy.referrer.json | R5: Healthcare professional who requested or referred the genomic study (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-GenomicStudy.startDate.json | R5: When the genomic study was started (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-GenomicStudy.status.json | R5: registered | available | cancelled | entered-in-error | unknown (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-GenomicStudy.type.json | R5: The type of the study (e.g., Familial variant segregation, Functional variation detection, or Gene expression profiling) (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Goal.achievementStatus.json | R5: in-progress | improving | worsening | no-change | achieved | sustaining | not-achieved | no-progress | not-attainable additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Goal.lifecycleStatus.json | R5: proposed | planned | accepted | active | on-hold | completed | cancelled | entered-in-error | rejected additional codes | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Goal.tar.detail.json | R5: detail additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-GraphDefinition.contact.json | R5: contact additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Group.cha.value.json | R5: value additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Group.managingEntity.json | R5: Entity that is the custodian of the Group's definition (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-GuidanceResponse.module.json | R5: What guidance was requested additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-GuidanceResponse.requestIdentifier.json | R5: The identifier of the request associated with this response, if any additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-HealthcareService.communication.json | R5: The language that this service is offered in (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-HealthcareService.program.json | R5: Programs that this service is applicable to (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Identifier.use.json | R5: usual | official | temp | secondary | old (If known) | trial-use | 0 | fhir | 2026-03 | uv | |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImagingSelection.basedOn.json | R5: Associated request (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImagingSelection.bodySite.json | R5: Body part examined (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImagingSelection.category.json | R5: Classifies the imaging selection (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImagingSelection.code.json | R5: Imaging Selection purpose text or code (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImagingSelection.derivedFrom.json | R5: The imaging study from which the imaging selection is derived (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImagingSelection.endpoint.json | R5: The network service providing retrieval for the images referenced in the imaging selection (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImagingSelection.focus.json | R5: Related resource that is the focus for the imaging selection (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImagingSelection.frameOfReferenceUid.json | R5: The Frame of Reference UID for the selected images (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImagingSelection.instance.json | R5: The selected instances (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImagingSelection.issued.json | R5: Date / Time when this imaging selection was created (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImagingSelection.performer.json | R5: Selector of the instances (human or machine) (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImagingSelection.seriesNumber.json | R5: DICOM Series Number (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImagingSelection.seriesUid.json | R5: DICOM Series Instance UID (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImagingSelection.status.json | R5: available | entered-in-error | unknown (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImagingSelection.studyUid.json | R5: DICOM Study Instance UID (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImagingStudy.location.json | R5: Where ImagingStudy occurred (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImagingStudy.note.json | R5: User-defined comments (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImagingStudy.ser.ins.sopClass.json | R5: sopClass additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImagingStudy.ser.ins.uid.json | R5: DICOM SOP Instance UID additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImagingStudy.ser.per.function.json | R5: Type of performance (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImagingStudy.ser.specimen.json | R5: Specimen imaged (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImagingStudy.ser.uid.json | R5: DICOM Series Instance UID for the series additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Immunization.fundingSource.json | R5: Funding source for the vaccine (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Immunization.isSubpotent.json | R5: Dose potency (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Immunization.occurrence.json | R5: Vaccine administration date additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Immunization.pro.programStatus.json | R5: The patient's eligibility status for the program (new) | trial-use | 0 | fhir | 2026-03 | uv | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Immunization.pro.program.json | R5: The program that eligibility is declared for (new) | trial-use | 0 | fhir | 2026-03 | uv | 3 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Immunization.pro.doseNumber.json | R5: doseNumber additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Immunization.pro.seriesDoses.json | R5: seriesDoses additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Immunization.statusReason.json | R5: Reason for current status additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Immunization.status.json | R5: completed | entered-in-error | not-done additional codes | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Immunization.subpotentReason.json | R5: Reason for being subpotent (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.authority.json | R5: Who is responsible for publishing the recommendations (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.date.json | R5: Date evaluation was performed (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.description.json | R5: Evaluation notes (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.doseNumber.json | R5: Dose number within series (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.doseStatusReason.json | R5: Reason why the doese is considered valid, invalid or some other status (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.doseStatus.json | R5: Status of the dose relative to published recommendations (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.immunizationEvent.json | R5: Immunization being evaluated (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.patient.json | R5: Who this evaluation is for (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.seriesDoses.json | R5: Recommended number of doses for immunity (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.series.json | R5: Name of vaccine series (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.status.json | R5: completed | entered-in-error (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.targetDisease.json | R5: The vaccine preventable disease schedule being evaluated (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-IR.rec.cVC.json | R5: Vaccine which is contraindicated to fulfill the recommendation (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-IR.rec.doseNumber.json | R5: Recommended dose number within series additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-IR.rec.forecastReason.json | R5: Vaccine administration status reason (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.contact.json | R5: contact additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.def.page.json | R5: Page/Section in the Guide (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.def.par.code.json | R5: Code that identifies parameter additional types | trial-use | 0 | fhir | 2026-03 | uv | 3 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.definition.json | R5: Information needed to build the IG (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.glo.profile.json | R5: profile additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.license.json | R5: SPDX license code for this IG (or not-open-source) (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.manifest.json | R5: Information about an assembled IG (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.packageId.json | R5: NPM Package name for IG (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.title.json | R5: Name for this implementation guide (human friendly) (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.allergenicIndicator.json | R5: If the ingredient is a known or suspected allergen (new) | trial-use | 0 | fhir | 2026-03 | uv | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.comment.json | R5: A place for providing any notes that are relevant to the component, e.g. removed during process, adjusted for loss on drying (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.for.json | R5: The product which this ingredient is a constituent part of (new) | trial-use | 0 | fhir | 2026-03 | uv | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.function.json | R5: Precise action within the drug product, e.g. antioxidant, alkalizing agent (new) | trial-use | 0 | fhir | 2026-03 | uv | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.group.json | R5: A classification of the ingredient according to where in the physical item it tends to be used, such the outer shell of a tablet, inner body or ink (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.manufacturer.json | R5: An organization that manufactures this ingredient (new) | trial-use | 0 | fhir | 2026-03 | uv | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.role.json | R5: Purpose of the ingredient within the product, e.g. active, inactive (new) | trial-use | 0 | fhir | 2026-03 | uv | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.status.json | R5: draft | active | retired | unknown (new) | trial-use | 0 | fhir | 2026-03 | uv | 3 |
| hl7.fhir.uv.xver-r5.r4b | R4B | StructureDefinition/StructureDefinition-ext-R5-Ingredient.sub.str.basis.json | R5: A code that indicates if the strength is, for example, based on the ingredient substance as stated or on the substance base (when the ingredient is a salt) (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r4b | R4B | StructureDefinition/StructureDefinition-ext-R5-Ingredient.sub.str.concentration.json | R5: concentration additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r4b | R4B | StructureDefinition/StructureDefinition-ext-R5-Ingredient.sub.str.presentation.json | R5: presentation additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r4b | R4B | StructureDefinition/StructureDefinition-ext-R5-Ingredient.sub.str.ref.strength.json | R5: strength additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.substance.json | R5: The substance that comprises this ingredient (new) | trial-use | 0 | fhir | 2026-03 | uv | 3 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.administeredBy.json | R5: Product administrator (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.alias.json | R5: Alternate names (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.coverageArea.json | R5: Where product applies (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.coverage.json | R5: Coverage details (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.endpoint.json | R5: Technical endpoint (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.name.json | R5: Official name (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.network.json | R5: What networks are Included (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.ownedBy.json | R5: Product issuer (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.period.json | R5: When the product is available (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.plan.json | R5: Plan details (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.status.json | R5: draft | active | retired | unknown (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.type.json | R5: Kind of product (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.association.json | R5: Association with other items or products (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.baseUnit.json | R5: The base unit of measure - the unit in which the product is used or counted (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.category.json | R5: Category or class of the item (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.characteristic.json | R5: Characteristic of the item (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.code.json | R5: Code designating the specific type of item (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.description.json | R5: Descriptive characteristics of the item (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.instance.json | R5: Instances or occurrences of the product (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.inventoryStatus.json | R5: The usage status like recalled, in use, discarded (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.name.json | R5: The item name(s) - the brand name, or common name, functional name, generic name or others (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.netContent.json | R5: Net content or amount present in the item (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.productReference.json | R5: Link to a product resource used in clinical workflows (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.responsibleOrganization.json | R5: Organization(s) responsible for the product (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.status.json | R5: active | inactive | entered-in-error | unknown (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.countType.json | R5: snapshot | difference (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.inventoryListing.json | R5: An inventory listing section (grouped by any of the attributes) (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.note.json | R5: A note associated with the InventoryReport (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.operationTypeReason.json | R5: The reason for this count - regular count, ad-hoc count, new arrivals, etc (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.operationType.json | R5: addition | subtraction (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.reportedDateTime.json | R5: When the report has been submitted (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.reporter.json | R5: Who submits the report (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.reportingPeriod.json | R5: The period the report refers to (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.status.json | R5: draft | requested | active | entered-in-error (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.account.json | R5: Account that is being balanced (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.cancelledReason.json | R5: Reason for cancellation of this Invoice (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.date.json | R5: DEPRICATED (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.issuer.json | R5: Issuing Organization of Invoice (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.lineItem.json | R5: Line items of this Invoice (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.note.json | R5: Comments made about the invoice (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.participant.json | R5: Participant in creation of this Invoice (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.paymentTerms.json | R5: Payment details (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.recipient.json | R5: Recipient of this invoice (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.status.json | R5: draft | issued | balanced | cancelled | entered-in-error (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.totalGross.json | R5: Gross total of this Invoice (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.totalNet.json | R5: Net total of this Invoice (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.type.json | R5: Type of Invoice (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Library.author.json | R5: Who authored the content additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Library.contact.json | R5: contact additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Library.editor.json | R5: Who edited the content additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Library.endorser.json | R5: Who endorsed the content additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Library.reviewer.json | R5: Who reviewed the content additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Library.subject.json | R5: Type of individual the library content is focused on (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Library.subtitle.json | R5: Subordinate title of the library (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ManufacturedItemDefinition.component.json | R5: Physical parts of the manufactured item, that it is intrisically made from. This is distinct from the ingredients that are part of its chemical makeup (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ManufacturedItemDefinition.ingredient.json | R5: The ingredients of this manufactured item. Only needed if these are not specified by incoming references from the Ingredient resource (new) | trial-use | 0 | fhir | 2026-03 | uv | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MID.manufacturedDoseForm.json | R5: Dose form as manufactured (before any necessary transformation) (new) | trial-use | 0 | fhir | 2026-03 | uv | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ManufacturedItemDefinition.manufacturer.json | R5: Manufacturer of the item, one of several possible (new) | trial-use | 0 | fhir | 2026-03 | uv | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ManufacturedItemDefinition.marketingStatus.json | R5: Allows specifying that an item is on the market for sale, or that it is not available, and the dates and locations associated (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ManufacturedItemDefinition.name.json | R5: A descriptive name applied to this item (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4b | R4B | StructureDefinition/StructureDefinition-ext-R5-MID.pro.value.json | R5: value additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ManufacturedItemDefinition.property.json | R5: General characteristics of this item (new) | trial-use | 0 | fhir | 2026-03 | uv | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ManufacturedItemDefinition.status.json | R5: draft | active | retired | unknown (new) | trial-use | 0 | fhir | 2026-03 | uv | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ManufacturedItemDefinition.unitOfPresentation.json | R5: The “real-world” units in which the quantity of the item is described (new) | trial-use | 0 | fhir | 2026-03 | uv | 3 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MarketingStatus.country.json | R5: The country in which the marketing authorization has been granted shall be specified It should be specified using the ISO 3166 ‑ 1 alpha-2 code elements (new) | trial-use | 0 | fhir | 2026-03 | uv | |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MarketingStatus.dateRange.json | R5: The date when the Medicinal Product is placed on the market by the Marketing Authorization Holder (or where applicable, the manufacturer/distributor) in a country and/or jurisdiction shall be provided A complete date consisting of day, month and year shall be specified using the ISO 8601 date format NOTE “Placed on the market” refers to the release of the Medicinal Product into the distribution chain (new) | trial-use | 0 | fhir | 2026-03 | uv | |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MarketingStatus.jurisdiction.json | R5: Where a Medicines Regulatory Agency has granted a marketing authorization for which specific provisions within a jurisdiction apply, the jurisdiction can be specified using an appropriate controlled terminology The controlled term and the controlled term identifier shall be specified (new) | trial-use | 0 | fhir | 2026-03 | uv | |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MarketingStatus.restoreDate.json | R5: The date when the Medicinal Product is placed on the market by the Marketing Authorization Holder (or where applicable, the manufacturer/distributor) in a country and/or jurisdiction shall be provided A complete date consisting of day, month and year shall be specified using the ISO 8601 date format NOTE “Placed on the market” refers to the release of the Medicinal Product into the distribution chain (new) | trial-use | 0 | fhir | 2026-03 | uv | |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MarketingStatus.status.json | R5: This attribute provides information on the status of the marketing of the medicinal product See ISO/TS 20443 for more information and examples (new) | trial-use | 0 | fhir | 2026-03 | uv | |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.author.json | R5: Who authored the content additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.contact.json | R5: contact additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.editor.json | R5: Who edited the content additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.endorser.json | R5: Who endorsed the content additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.gro.code.json | R5: Meaning of the group additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.gro.str.code.json | R5: Meaning of the stratifier additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.gro.str.component.json | R5: Stratifier criteria component for the measure (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.gro.str.description.json | R5: The human readable description of this stratifier (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.improvementNotation.json | R5: increase | decrease additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.library.json | R5: library additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.reviewer.json | R5: Who reviewed the content additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.subject.json | R5: E.g. Patient, Practitioner, RelatedPerson, Organization, Location, Device (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.subtitle.json | R5: Subordinate title of the measure (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.sup.code.json | R5: Meaning of the supplemental data additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.sup.description.json | R5: The human readable description of this supplemental data (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MeasureReport.gro.code.json | R5: Meaning of the group additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MeasureReport.gro.str.code.json | R5: code additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MeasureReport.gro.str.str.component.json | R5: Stratifier component values (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MeasureReport.improvementNotation.json | R5: increase | decrease (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MeasureReport.measure.json | R5: What measure was calculated additional types | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MeasureReport.type.json | R5: individual | subject-list | summary | data-exchange | trial-use | 0 | fhir | 2026-03 | uv | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Medication.batch.json | R5: Details about packaged medications (new) | trial-use | 0 | fhir | 2026-03 | uv | 1 |
FHIR IG analytics
FHIR
FHIRsmith